Agile Therapeutics reported 17.06M in Operating Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Aceto ACET:US 17.14M 1.5M
Adma Biologics ADMA:US $ 35.12M 1.71M
Agile Therapeutics AGRX:US 17.06M 775K
Bayer BAYN:GR 9.25B 3.88B
Biodelivery Sciences International BDSI:US $ 25.47M 4.6M
Biomarin Pharmaceutical BMRN:US $ 461.96M 28.06M
JAZZ PHA JAZZ:US $ 809.75M 11.66M
Johnson & Johnson JNJ:US $ 19.49B 2.84B
Merk MRK:US $ 8328M 1460M
Pacira Pharmaceuticals PCRX:US $ 96.29M 4.46M
Pain Therapeutics PTIE:US $ 9.75M 4.62M
Pfizer PFE:US $ 16447M 3384M
Teva Pharmaceutical Industries TEVA:US 3.26B 64M
Therapeuticsmd TXMD:US 65.33M 7.15M